Navigation Links
PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
Date:12/7/2012

t PROLOR's poster, "Factor VIIa-CTP,a Novel Long-Acting Coagulation Factor with Enhanced Long Term Haemostatic Effect and Improved Pharmacokinetics and Pharmacodynamic Properties Following IV Administration in Hemophilic Animal Models," on December 8, 2012 at 5.30 pm EST. The 2012 ASH Annual Meeting is being held December 8-11, 2012 in Atlanta, Georgia.  For more information, visit www.hematology.org/Meetings/Annual-Meeting/.

ABOUT PROLOR
PROLOR Biotech, Inc. is a clinical stage biopharmaceutical company applying unique technologies, including patented CTP technology and its long-acting reversible-pegylation technology, primarily to develop longer-acting proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales.  The CTP technology is applicable to virtually all proteins.  PROLOR is developing a long-acting version of human growth hormone, which successfully completed a Phase II clinical trial.  It also is developing long-acting versions of Factor VIIa and Factor IX for hemophilia and a GLP-1/Glucagon dual receptor agonist peptide for diabetes and obesity, all of which are in preclinical development.  For more information, visit www.prolor-biotech.com.

Safe Harbor Statement:  This press release contains forward-looking statements, which may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "would", "intends," "estimates," "suggests," "has the potential to" and other words of similar meaning, including statements regarding the results of current clinical studies and preclinical experiments and the effectiveness of PROLOR's long-acting protein programs, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. 
'/>"/>

SOURCE PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GenWay Biotech Appoints New Vice President of Custom/OEM
2. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
4. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
5. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
6. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
7. Obamacare Ruling, Other Pivotal News Rocks Biotech Sector in June
8. Tougher Times May be Ahead for Biotechs: 1H12 Fundraising Slows
9. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Lifeline Biotechnologies First Warning Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , March 6, 2015 Lucerne Biosciences, ... Office,s publication of U.S. Patent Application No. 14/464,249 ... Patent Application features claimed methods of "informing a ... to treat Binge Eating Disorder (,BED,)," including by ... "flyer or an advertisement," as well as by ...
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)...  IRIDEX Corporation (Nasdaq: IRIX ) today reported ... 3, 2015.  , Revenues were $11.8 million in ... and up 11% from $10.6 million in the 2013 fourth ... up 12% from $38.3 million in 2013. , Gross ... 48.6% in the fourth quarter of the prior year. ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8
... ... 15 SRI International, an independent nonprofit research and development organization, ... bioadhesive drug delivery system that enables enhanced release of drugs through ... drug delivery and allows for a much longer release time compared ...
... , KNOXVILLE, Tenn., Dec. 15 Medical researchers with EDP ... new technology for a simple blood test to detect early-stage ... pre-clinical trials for the ColoMarker(TM) assay, EDP has filed a ... use. Via an inexpensive blood test, ColoMarker(TM) will detect ...
Cached Medicine Technology:SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2
(Date:3/6/2015)... 06, 2015 Los Angeles cosmetic dentist ... for Zoom whitening. Zoom is a special type of teeth ... Unlike other teeth whitening treatments, Zoom does its job in ... stains. For a limited time, Dr. Ghasri is offering Zoom ... usual price of $650 and allows patients to try out ...
(Date:3/6/2015)... March 06, 2015 Medical Products, Inc., ... an agreement with GE Healthcare to become an authorized ... United States. , MPI has 31 years in distribution ... Healthcare. , With this agreement, MPI will have the ... the healthcare industry. , MPI has always strived ...
(Date:3/5/2015)... (PRWEB) March 06, 2015 In 2014, ... being first–in-class. AstraZeneca tops the list scoring 4 drug ... over 25% of all FDA approved drug products, followed ... mechanisms such as anti-PCSK9, anti-PD1 and CDK inhibitors keep ... approved by the FDA to treat metastatic melanoma, and ...
(Date:3/5/2015)... March 05, 2015 A Bakersfield, Calif. state ... seven-week trial awarding the plaintiff Coleen M. Perry a ... result of a TVT-Abbrevo pelvic mesh sling device, manufactured by ... Tom Cartmell , a partner at Wagstaff & Cartmell ... for the plaintiff, along with Rich Freese and Tim Goss ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to ... new logo and optimized website. , CNI’s ... to expert diagnostic imaging, centered on patient care. The ... be a resource for Nebraska patients and a tool ... and referral functionality, video content and resources to understand ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Central Nebraska Imaging Center Gets Rebranding 2
... A study of 62 youngsters has revealed that low tar, ... severely as regular cigarettes . ,All the participants ... Heart, were in their mid-twenties. ,Twenty of them ... three years, while 20 other participants had smoked regular cigarettes ...
... A new research has found that extremely anxious patients with ... or death when compared to those with a calmer ... time were in greatest danger, while those who initially had ... their risk. ,"Most patients come in very anxious ...
... a solution for the embarrassing problem of bad breath or ... paste that can tackle separate causes of smelly breath. ... dihydrogen sulphide, which can lead to bad breath, reports the ... enzyme that fights starch and cellulose in between the teeth ...
... have higher dietary intake of foods with omega-3 fatty acids ... age-related macular degeneration, while those with higher serum levels ... early stages of the disease, according to two reports in ... JAMA/Archives journals. ,Age-related macular degeneration (AMD) occurs when ...
... surgical removal of the prostate due to cancer may ... not worry about the post-surgical urinary incontinence. ... at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has devised a ... ensure continence. ,They describe the success of ...
... to take a heavy toll the world over. Almost 100 million ... as infants. ,According to a searing report on the ... the increase in many developing countries, where a male child ... International - a global child development agency - highlights the fact ...
Cached Medicine News:Health News:Risk of Heart Attack, Death High Among Extremely Anxious Patients 2Health News:Risk of Heart Attack, Death High Among Extremely Anxious Patients 3Health News:Higher Intake of Fish and Vitamin D Reduces the Risk of Age-related Macular Disease 2Health News:Higher Intake of Fish and Vitamin D Reduces the Risk of Age-related Macular Disease 3Health News:Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy 2Health News:Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy 3Health News:Female Infanticide and Feticide Continue to Increase 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: